PURANDARE ASHOK V.,GREBINSKI JAMES W.,HART AMY,INGHRIM JENNIFER,SCHROEDER GRETCHEN,WAN HONGHE
申请号：
TN2012000062
公开号：
TN2012000062A1
申请日:
2012.02.10
申请国别(地区):
TN
年份:
2013
代理人:
摘要：
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The formula (I) compounds inhibit tyrosine kinase activity of JAK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.
